Migraines are chronic, severe headaches that can last for hours and even days. Approximately 10% of the U.S. population suffers from migraines; about half of all migraines are severe enough to be disabling. Children are not exempt; about 10% of children between the ages of 5 and 15 report having migraine headaches, and about 28% of adolescents aged 15 to 19.

Some migraines, but not all, are preceded by what’s called an “aura,” which are early warning signs that may include flashes of light, blind spots in the field of vision, or tingling in the extremities.

The pain is often severe, pulsing or throbbing, and may be located on one side of the head or both. The pain typically worsens with physical activity, and migraine sufferers generally need a quiet, dark place to lie down and rest. Migraines often include nausea, vomiting, and extreme sensitivity to light or noise.

Artemis Institute for Clinical Research conducts clinical trials of investigative medications for the treatment of migraines in adults, children, and adolescents. Qualified individuals participating in a trial may be eligible to receive financial compensation for time and travel, study-related medical and psychological evaluations, and the investigative study medication at no cost.

If you or your child has experienced some or all of the symptoms described and would like to volunteer for a study, or if you know someone suffering from migraines who may want to volunteer, please send us your request using the Join a Study form, or call us toll-free at 855-DoStudies (855.367.8834).

Application for Migraines Clinical Research Study

Join Now!

Or Learn More About Another Study Area

Study Areas

Binge Eating Disorder
Alcohol & Drug Abuse
Alzheimer's Disease
Anxiety Disorder
Bipolar Disorder
Gastrointestinal Disorders
Infectious Disease
Insomnia & Sleep Disorder
Lower Back Pain
Respiratory System
Women's Health
prev next

Contact Us

"*" Indicates Required Information
All information provided is confidential and will not be given or sold to any other agency without prior consent. Click here to view our Privacy Policy.